X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/magenta-hoists-dianthus-its-shoulders-reverse-merger-securing-final-lifeline-shareholders
https://endpts.com/magenta-therapeutics-to-merge-with-dianthus-in-all-stock-deal/
https://www.globenewswire.com/news-release/2023/05/03/2660170/0/en/Magenta-Therapeutics-and-Dianthus-Therapeutics-Announce-Merger-Agreement.html
https://www.globenewswire.com/news-release/2023/03/31/2639026/0/en/Magenta-Therapeutics-Adopts-Limited-Duration-Stockholder-Rights-Plan.html
https://endpts.com/magenta-ceo-exits-84-of-staff-let-go-as-shuttering-looms/
https://www.fiercebiotech.com/biotech/days-after-halting-leukemia-drug-magenta-moves-close-its-doors
https://www.globenewswire.com/news-release/2023/02/02/2600963/0/en/Magenta-Therapeutics-to-Explore-Strategic-Alternatives.html
https://www.globenewswire.com/news-release/2023/01/25/2595611/0/en/Magenta-Therapeutics-Voluntarily-Pauses-the-MGTA-117-Phase-1-2-Dose-Escalation-Clinical-Trial-to-Investigate-Drug-Safety.html
https://www.globenewswire.com/news-release/2022/12/20/2577128/0/en/Magenta-Therapeutics-Provides-Update-for-MGTA-117-Phase-1-2-Dose-Escalation-Clinical-Trial.html
https://www.fiercebiotech.com/biotech/magenta-halts-high-dose-group-leukemia-trial-after-serious-adverse-events
Market Place
Share 
